trending Market Intelligence /marketintelligence/en/news-insights/trending/swt-5y8_bulroq9nz0prhw2 content esgSubNav
In This List

ProQR prices common stock offering

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


ProQR prices common stock offering

ProQR Therapeutics NV priced an underwritten public offering of 5,750,000 ordinary shares at $15.75 each.

The Netherlands-based biopharmaceutical company expects to raise gross proceeds of about $90.6 million through the offering, which is expected to close Sept. 11, subject to customary closing conditions.

Underwriters have a 30-day option to buy up to 862,500 additional ordinary shares at the offering price.

Citigroup, Evercore ISI and RBC Capital Markets are acting as joint book runners for the offering, with H.C. Wainwright & Co. and Chardan as co-managers. Kempen & Co. is acting as ProQR's European financial adviser for the offering.